2016 was not a good year for new medicines. The U.S. Food and Drug Administration cleared just 22 new drugs for sale last year, the lowest number since 2010 and a sharp decline from 2015's total of 45 approved drugs. While the FDA simply delayed approval on some applications that will likely be given the green light in 2017, there's also been a decline in applications overall, Reuters reports. Despite recent advances in cancer treatment and other genetic diseases, drug companies are finding difficulty securing financial returns due to political pushback against the rising costs of medicine. Returns on research and development investment at the top 12 pharmaceutical companies fell to 3.7 percent in 2016, from a high of 10.1 percent in 2010.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
How quarterly estimated tax payments work and when they are dueThe Explainer Freelancers, small business owners and those with a side hustle may need to make more frequent tax payments
-
'Alligator Alcatraz will be a blight on the Everglades'Instant Opinion Opinion, comment and editorials of the day
-
Kirsty Coventry: the former Olympian and first woman to lead the IOCIn the Spotlight Coventry, a former competitive swimmer, won two Olympic gold medals
-
Economists fear US inflation data less reliablespeed read The Labor Department is collecting less data for its consumer price index due to staffing shortages
-
Crypto firm Coinbase hacked, faces SEC scrutinySpeed Read The Securities and Exchange Commission has also been investigating whether Coinbase misstated its user numbers in past disclosures
-
Starbucks baristas strike over dress codespeed read The new uniform 'puts the burden on baristas' to buy new clothes, said a Starbucks Workers United union delegate
-
Warren Buffet announces surprise retirementspeed read At the annual meeting of Berkshire Hathaway, the billionaire investor named Vice Chairman Greg Abel his replacement
-
Trump calls Amazon's Bezos over tariff displaySpeed Read The president was not happy with reports that Amazon would list the added cost from tariffs alongside product prices
-
Markets notch worst quarter in years as new tariffs loomSpeed Read The S&P 500 is on track for its worst month since 2022 as investors brace for Trump's tariffs
-
Tesla Cybertrucks recalled over dislodging panelsSpeed Read Almost every Cybertruck in the US has been recalled over a stainless steel panel that could fall off
-
Crafting emporium Joann is going out of businessSpeed Read The 82-year-old fabric and crafts store will be closing all 800 of its stores
